Area-level income and colorectal cancer screening among urban-dwelling Canadians: Evidence to guide future surveillance
Authors: A. Blair, L. Gauvin, S. Ouédraogo, and G. Datta.
Background Participation in colorectal screening remains low even in countries with universal health coverage. Area-level determinants of low screening participation in Canada remain poorly understood. Methods We assessed the association between area-level income and two indicators of colorectal screening (having never been screened, having not been screened recently) by linking census-derived local area-level income data with self-reported screening data from urban-dwelling respondents to the Canadian Community Health Survey (50-75 years of age, cycles 2005 and 2007, n = 18,362) who reported no known risk factors for colorectal cancer. Generalized estimating equation Poisson models estimated the prevalence ratios and differences for having never been screened and having not been screened recently, adjusting for individual-level income, education, marital status, having a regular physician, age, and sex. Results About 53% of the study population had never been screened. Among individuals who had ever been screened, 35% had been screened recently. Adjusting for covariates, lower area-level income was associated with having never been screened [covariate-adjusted prevalence ratios: 1.24 for quartile 1; 95% confidence limits (cl): 1.16, 1.34; 1.25 for quartile 2; 95% cl: 1.15, 1.33; 1.15 for quartile 3; 95% cl: 1.08, 1.23]. Among individuals who had been screened in their lifetime, area-level income was not associated with having not been screened recently. Conclusions Lower area-level income is associated with having never been screened for colorectal cancer even after adjusting for individual socioeconomic factors. Those findings highlight the potential importance of socioeconomic contexts for colorectal screening initiation and merit attention in both future research and surveillance efforts.
Please note that abstracts only appear in the language of the publication and might not have a translation.
Michelle Le, Feras M. Ghazawi, Akram Alakel, Elena Netchiporouk, Elham Rahme, Andrei Zubarev, Mathieu Powell, Linda Moreau, Osama Roshdy, Steven J. Glassman, Denis Sasseville, Gizelle Popradi, and Ivan V. Litvinov (2019).
Incidence and mortality trends and geographic patterns of follicular lymphoma in Canada
Current Oncology , e473-e481
Y. Yuan, J. Ross, Q. Shi, and F. G. Davis (2017).
Conditional survival after a diagnosis of malignant brain tumour in Canada: 2000-2008
Current Oncology , 341-347
Simon F. Roy, Feras M. Ghazawi, Michelle Le, François Lagacé, Catherine F. Roy, Elham Rahme, Evgeny Savin, Andrei Zubarev, Denis Sasseville, Gizelle Popradi, and Ivan V. Litvinov (2020).
Epidemiology of adult and pediatric Burkitt Lymphoma in Canada: Sequelae of the HIV epidemic
Current Oncology , 83-89
J. Tung, C. E. Politis, J. Chadder, J. Han, J. Niu, S. Fung, R. Rahal, and C. C. Earle (2018).
The north-south and east-west gradient in colorectal cancer risk: A look at the distribution of modifiable risk factors and incidence across Canada
Current Oncology , 231-235
A. C. Coronado, C. Finley, K. Badovinac, J. Han, J. Niu, and R. Rahal (2018).
Discrepancies between Canadian cancer research funding and site-specific cancer burden
Current Oncology , 338-341
Emily V. Walker, J. Ross, Y. Yuan, T. R. Smith, and F. G. Davis (2019).
Brain cancer survival in Canada 1996-2008: Effects of sociodemographic characteristics
Current Oncology , 292-299
Laetitia Amar, Michelle Le, Feras M. Ghazawi, Elham Rahme, Amanda Segal, Elena Netchiporouk, Gizelle Popradi, Linda Moreau, Osama Roshdy, Denis Sasseville, and Ivan Litvinov (2019).
Prevalence of human T cell lymphotropic virus 1 infection in Canada
Current Oncology , e3-e5